Analytical Chemistry Advisor/Senior Advisor, Cell & Gene Therapy Products - Bioproduct Research and Development at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Ph.D. in Analytical Chemistry, Biochemistry, Chemistry, or related field, MS with 5+ years of experience, or BS with 10+ years of experience
  • Experience with analytical control strategy development from pre-FHD to commercial launch (preferred)
  • Demonstrated proficiency with drug development for cell and gene therapy products (preferred)
  • Experience with chromatographic separations (reversed phase chromatography, ion exchange chromatography, size exclusion chromatography), capillary electrophoresis, spectroscopic methods, and other methods for the analysis of cell and gene therapy products (preferred)
  • Knowledge of ddPCR and ELISA, and cell-based bioassay for analysis of cell and gene therapy products (preferred)
  • Effective oral and written communication skills (preferred)
  • Experience across multiple analytical techniques
  • Aptitude in technical problem-solving
  • Ability to work both independently and collaboratively in a dynamic environment

Responsibilities

  • Enable the design, development, and implementation of analytical methodologies for the characterization and analysis of cell and gene therapy products
  • Contribute to the establishment of robust control strategies through generation of data, development of analytical methods, design and execution of stability strategies
  • Engage with scientists across development and manufacturing as well as through collaboration with external development partners to design and implement control strategies for projects at various stages of development
  • Responsible for evaluating and/or implementing new analytical technologies/methods to advance Lilly’s current analytical capabilities
  • Spearhead new initiatives to improve existing scientific processes within the organization and across the company
  • Identify and exploit new scientific concepts, strong problem-solving skills, and be self-motivated to contribute across multiple projects
  • Demonstrate strong written and verbal communication skills to speak to both technical and business-related implications of your works

Skills

Analytical Chemistry
HPLC
Mass Spectrometry
Spectroscopy
Chromatography
Cell Therapy
Gene Therapy
Bioproduct Development
Pharmaceutical Analysis
GMP
Method Development

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI